{"id":12094,"date":"2018-12-17T16:43:50","date_gmt":"2018-12-17T15:43:50","guid":{"rendered":"https:\/\/www.retarus.com\/blog\/de\/?p=12094"},"modified":"2019-05-15T14:21:14","modified_gmt":"2019-05-15T12:21:14","slug":"patient-zero-detection-retarus-erhaelt-europaweites-patent","status":"publish","type":"post","link":"https:\/\/www.retarus.com\/blog\/de\/patient-zero-detection-retarus-erhaelt-europaweites-patent\/","title":{"rendered":"Patient Zero Detection<sup>&reg;<\/sup>: Retarus erh\u00e4lt europaweites Patent"},"content":{"rendered":"<p>Das Europ\u00e4ische Patentamt hat der von Retarus entwickelten Technologie Patient Zero Detection<sup>\u00ae<\/sup> ein <a href=\"https:\/\/register.epo.org\/application?number=EP16150573\" target=\"_blank\" rel=\"noopener noreferrer\">europaweites Patent<\/a> erteilt. Das innovative Verfahren zur Analyse und Erkennung gef\u00e4hrlicher E-Mails ist integraler Bestandteil der umfassenden <a href=\"https:\/\/www.retarus.com\/de\/services\/email-security\/\">E-Mail Security Services<\/a> des globalen Anbieters von Informationslogistik. Patient Zero Detection<sup>\u00ae<\/sup> identifiziert Empf\u00e4nger zuvor unbekannter, neuer Schadprogramme binnen k\u00fcrzester Zeit. Dies erm\u00f6glicht es Administratoren, schneller zu reagieren und, etwa im Fall von Ransomware, erheblichen Schaden vom Unternehmen rechtzeitig abzuwenden.<\/p>\n<p>Umfangreiche Filterfunktionen von Virenschutz-Programmen blockieren E-Mails mit bekannter Malware heute meist zuverl\u00e4ssig, bevor sie in die IT-Infrastruktur gelangen. Jedoch bietet kein Virenfilter ausreichenden Schutz vor gezielten Angriffen mit bislang unbekannten oder abgewandelten Angriffsmustern. Beim ersten Auftreten gelangt solche Malware daher h\u00e4ufig unbemerkt ins Unternehmensnetz.<\/p>\n<div id=\"attachment_11851\" style=\"width: 1290px\" class=\"wp-caption alignnone\"><a href=\"https:\/\/www.retarus.com\/blog\/de\/wp-content\/uploads\/sites\/4\/2018\/08\/martin-16zu9.jpg\"><img aria-describedby=\"caption-attachment-11851\" decoding=\"async\" src=\"https:\/\/www.retarus.com\/blog\/de\/wp-content\/uploads\/sites\/4\/2018\/08\/martin-16zu9.jpg\" alt=\"\" width=\"1280\" height=\"720\" class=\"size-full wp-image-11851\"><\/a><p id=\"caption-attachment-11851\" class=\"wp-caption-text\">Martin Hager, Gr\u00fcnder und  Gesch\u00e4ftsf\u00fchrer von Retarus<\/p><\/div>\n<p>\u201eWir suchen daher immer nach neuen Wege, um den gestiegenen Sicherheitsanforderungen unserer Kunden gerecht zu werden\u201c, kommentiert Martin Hager, Gr\u00fcnder und Gesch\u00e4ftsf\u00fchrer von Retarus. \u201eDas nun erteilte Patent ist ein weiterer Beweis f\u00fcr die hervorragende Arbeit unseres Entwicklerteams und die hohe Innovationskraft von Retarus. Die Patentierung ist f\u00fcr uns gleichzeitig Ansporn, auch nach \u00fcber 25 Jahren Erfahrung im Bereich E-Mail-Sicherheit unsere Services \u201aMade in Germany\u2018 intensiv weiterzuentwickeln.\u201c<\/p>\n<p>Alle weitere Einzelheiten entnehmen Sie bitte unserer <a href=\"https:\/\/www.retarus.com\/de\/press\/retarus-erhaelt-europaweites-patent-fuer-mechanismus-zur-erkennung-gefaehrlicher-emails\/\">aktuellen Pressemitteilung<\/a>.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Das Europ\u00e4ische Patentamt hat der von Retarus entwickelten Technologie Patient Zero Detection<sup>&reg;<\/sup> ein europaweites Patent erteilt.<\/p>\n","protected":false},"author":14,"featured_media":12097,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"_et_pb_use_builder":"","_et_pb_old_content":"","_et_gb_content_width":"","_s2mail":"","footnotes":""},"categories":[7],"tags":[1328,328],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO Premium plugin v23.0 (Yoast SEO v23.0) - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>Patient Zero Detection&reg;: Retarus erh\u00e4lt europaweites Patent - Retarus Corporate Blog - DE<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.retarus.com\/blog\/de\/patient-zero-detection-retarus-erhaelt-europaweites-patent\/\" \/>\n<meta property=\"og:locale\" content=\"de_DE\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Patient Zero Detection&reg;: Retarus erh\u00e4lt europaweites Patent\" \/>\n<meta property=\"og:description\" content=\"Das Europ\u00e4ische Patentamt hat der von Retarus entwickelten Technologie Patient Zero Detection&reg; ein europaweites Patent erteilt.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.retarus.com\/blog\/de\/patient-zero-detection-retarus-erhaelt-europaweites-patent\/\" \/>\n<meta property=\"og:site_name\" content=\"Retarus Corporate Blog - DE\" \/>\n<meta property=\"article:published_time\" content=\"2018-12-17T15:43:50+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2019-05-15T12:21:14+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.retarus.com\/blog\/de\/wp-content\/uploads\/sites\/4\/2018\/12\/patient-zero-detection-2.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"977\" \/>\n\t<meta property=\"og:image:height\" content=\"550\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"Thomas Cloer\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Verfasst von\" \/>\n\t<meta name=\"twitter:data1\" content=\"Thomas Cloer\" \/>\n\t<meta name=\"twitter:label2\" content=\"Gesch\u00e4tzte Lesezeit\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 Minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\/\/www.retarus.com\/blog\/de\/patient-zero-detection-retarus-erhaelt-europaweites-patent\/\",\"url\":\"https:\/\/www.retarus.com\/blog\/de\/patient-zero-detection-retarus-erhaelt-europaweites-patent\/\",\"name\":\"Patient Zero Detection&reg;: Retarus erh\u00e4lt europaweites Patent - Retarus Corporate Blog - DE\",\"isPartOf\":{\"@id\":\"https:\/\/www.retarus.com\/blog\/de\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/www.retarus.com\/blog\/de\/patient-zero-detection-retarus-erhaelt-europaweites-patent\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/www.retarus.com\/blog\/de\/patient-zero-detection-retarus-erhaelt-europaweites-patent\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/www.retarus.com\/blog\/de\/wp-content\/uploads\/sites\/4\/2018\/12\/patient-zero-detection-2.jpg\",\"datePublished\":\"2018-12-17T15:43:50+00:00\",\"dateModified\":\"2019-05-15T12:21:14+00:00\",\"author\":{\"@id\":\"https:\/\/www.retarus.com\/blog\/de\/#\/schema\/person\/7f8954d8bf84d75cf384942c5f6cf2e5\"},\"breadcrumb\":{\"@id\":\"https:\/\/www.retarus.com\/blog\/de\/patient-zero-detection-retarus-erhaelt-europaweites-patent\/#breadcrumb\"},\"inLanguage\":\"de-DE\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/www.retarus.com\/blog\/de\/patient-zero-detection-retarus-erhaelt-europaweites-patent\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"de-DE\",\"@id\":\"https:\/\/www.retarus.com\/blog\/de\/patient-zero-detection-retarus-erhaelt-europaweites-patent\/#primaryimage\",\"url\":\"https:\/\/www.retarus.com\/blog\/de\/wp-content\/uploads\/sites\/4\/2018\/12\/patient-zero-detection-2.jpg\",\"contentUrl\":\"https:\/\/www.retarus.com\/blog\/de\/wp-content\/uploads\/sites\/4\/2018\/12\/patient-zero-detection-2.jpg\",\"width\":977,\"height\":550},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/www.retarus.com\/blog\/de\/patient-zero-detection-retarus-erhaelt-europaweites-patent\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/www.retarus.com\/blog\/de\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Patient Zero Detection&reg;: Retarus erh\u00e4lt europaweites Patent\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/www.retarus.com\/blog\/de\/#website\",\"url\":\"https:\/\/www.retarus.com\/blog\/de\/\",\"name\":\"Retarus Corporate Blog - DE\",\"description\":\"Immer up-to-date\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/www.retarus.com\/blog\/de\/?s={search_term_string}\"},\"query-input\":\"required name=search_term_string\"}],\"inLanguage\":\"de-DE\"},{\"@type\":\"Person\",\"@id\":\"https:\/\/www.retarus.com\/blog\/de\/#\/schema\/person\/7f8954d8bf84d75cf384942c5f6cf2e5\",\"name\":\"Thomas Cloer\",\"url\":\"https:\/\/www.retarus.com\/blog\/de\/author\/thomasc\/\"}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"Patient Zero Detection&reg;: Retarus erh\u00e4lt europaweites Patent - Retarus Corporate Blog - DE","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.retarus.com\/blog\/de\/patient-zero-detection-retarus-erhaelt-europaweites-patent\/","og_locale":"de_DE","og_type":"article","og_title":"Patient Zero Detection&reg;: Retarus erh\u00e4lt europaweites Patent","og_description":"Das Europ\u00e4ische Patentamt hat der von Retarus entwickelten Technologie Patient Zero Detection&reg; ein europaweites Patent erteilt.","og_url":"https:\/\/www.retarus.com\/blog\/de\/patient-zero-detection-retarus-erhaelt-europaweites-patent\/","og_site_name":"Retarus Corporate Blog - DE","article_published_time":"2018-12-17T15:43:50+00:00","article_modified_time":"2019-05-15T12:21:14+00:00","og_image":[{"width":977,"height":550,"url":"https:\/\/www.retarus.com\/blog\/de\/wp-content\/uploads\/sites\/4\/2018\/12\/patient-zero-detection-2.jpg","type":"image\/jpeg"}],"author":"Thomas Cloer","twitter_card":"summary_large_image","twitter_misc":{"Verfasst von":"Thomas Cloer","Gesch\u00e4tzte Lesezeit":"1 Minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/www.retarus.com\/blog\/de\/patient-zero-detection-retarus-erhaelt-europaweites-patent\/","url":"https:\/\/www.retarus.com\/blog\/de\/patient-zero-detection-retarus-erhaelt-europaweites-patent\/","name":"Patient Zero Detection&reg;: Retarus erh\u00e4lt europaweites Patent - Retarus Corporate Blog - DE","isPartOf":{"@id":"https:\/\/www.retarus.com\/blog\/de\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.retarus.com\/blog\/de\/patient-zero-detection-retarus-erhaelt-europaweites-patent\/#primaryimage"},"image":{"@id":"https:\/\/www.retarus.com\/blog\/de\/patient-zero-detection-retarus-erhaelt-europaweites-patent\/#primaryimage"},"thumbnailUrl":"https:\/\/www.retarus.com\/blog\/de\/wp-content\/uploads\/sites\/4\/2018\/12\/patient-zero-detection-2.jpg","datePublished":"2018-12-17T15:43:50+00:00","dateModified":"2019-05-15T12:21:14+00:00","author":{"@id":"https:\/\/www.retarus.com\/blog\/de\/#\/schema\/person\/7f8954d8bf84d75cf384942c5f6cf2e5"},"breadcrumb":{"@id":"https:\/\/www.retarus.com\/blog\/de\/patient-zero-detection-retarus-erhaelt-europaweites-patent\/#breadcrumb"},"inLanguage":"de-DE","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.retarus.com\/blog\/de\/patient-zero-detection-retarus-erhaelt-europaweites-patent\/"]}]},{"@type":"ImageObject","inLanguage":"de-DE","@id":"https:\/\/www.retarus.com\/blog\/de\/patient-zero-detection-retarus-erhaelt-europaweites-patent\/#primaryimage","url":"https:\/\/www.retarus.com\/blog\/de\/wp-content\/uploads\/sites\/4\/2018\/12\/patient-zero-detection-2.jpg","contentUrl":"https:\/\/www.retarus.com\/blog\/de\/wp-content\/uploads\/sites\/4\/2018\/12\/patient-zero-detection-2.jpg","width":977,"height":550},{"@type":"BreadcrumbList","@id":"https:\/\/www.retarus.com\/blog\/de\/patient-zero-detection-retarus-erhaelt-europaweites-patent\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.retarus.com\/blog\/de\/"},{"@type":"ListItem","position":2,"name":"Patient Zero Detection&reg;: Retarus erh\u00e4lt europaweites Patent"}]},{"@type":"WebSite","@id":"https:\/\/www.retarus.com\/blog\/de\/#website","url":"https:\/\/www.retarus.com\/blog\/de\/","name":"Retarus Corporate Blog - DE","description":"Immer up-to-date","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.retarus.com\/blog\/de\/?s={search_term_string}"},"query-input":"required name=search_term_string"}],"inLanguage":"de-DE"},{"@type":"Person","@id":"https:\/\/www.retarus.com\/blog\/de\/#\/schema\/person\/7f8954d8bf84d75cf384942c5f6cf2e5","name":"Thomas Cloer","url":"https:\/\/www.retarus.com\/blog\/de\/author\/thomasc\/"}]}},"_links":{"self":[{"href":"https:\/\/www.retarus.com\/blog\/de\/wp-json\/wp\/v2\/posts\/12094"}],"collection":[{"href":"https:\/\/www.retarus.com\/blog\/de\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.retarus.com\/blog\/de\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.retarus.com\/blog\/de\/wp-json\/wp\/v2\/users\/14"}],"replies":[{"embeddable":true,"href":"https:\/\/www.retarus.com\/blog\/de\/wp-json\/wp\/v2\/comments?post=12094"}],"version-history":[{"count":7,"href":"https:\/\/www.retarus.com\/blog\/de\/wp-json\/wp\/v2\/posts\/12094\/revisions"}],"predecessor-version":[{"id":13129,"href":"https:\/\/www.retarus.com\/blog\/de\/wp-json\/wp\/v2\/posts\/12094\/revisions\/13129"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.retarus.com\/blog\/de\/wp-json\/wp\/v2\/media\/12097"}],"wp:attachment":[{"href":"https:\/\/www.retarus.com\/blog\/de\/wp-json\/wp\/v2\/media?parent=12094"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.retarus.com\/blog\/de\/wp-json\/wp\/v2\/categories?post=12094"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.retarus.com\/blog\/de\/wp-json\/wp\/v2\/tags?post=12094"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}